Cita APA

Hardy-Werbin, M., Rocha, P. P., Arpí Llucià, O., Taus García, Á., Nonell Mazelon, L., Duran Jordà, X., . . . Arriola Aperribay, E. (2019). Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer.

Citación estilo Chicago

Hardy-Werbin, Max, et al. Serum Cytokine Levels As Predictive Biomarkers of Benefit From Ipilimumab in Small Cell Lung Cancer. 2019.

Cita MLA

Hardy-Werbin, Max, et al. Serum Cytokine Levels As Predictive Biomarkers of Benefit From Ipilimumab in Small Cell Lung Cancer. 2019.